Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
PHASE2
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
N/A
Background:
Atrial fibrillation (AF) is the most common heart rhythm disor...
Status
Recruiting
Location
Esbjerg Hospital - University Hospital of Southern Denmark, involving collaboration between the Unit for Thrombosis Research, Department of Clinical Diagnostics and the Department of Cardiology.
Start Date
2024-08-16
Trial ID
NCT06949319
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
PHASE2
The global pandemic COVID-19 has overwhelmed the medical capacity to accomm...